Stem/progenitors for liver, biliary tree, and pancreas exist at early stages of development in the definitive ventral endoderm forming the foregut. In humans, they persist postnatally as part of a network, with evidence supporting their contributions to hepatic and pancreatic organogenesis throughout life. Multiple stem cell niches persist in specific anatomical locations within the human biliary tree and pancreatic ducts. In liver and pancreas, replication of mature parenchymal cells ensures the physiological turnover and the restoration of parenchyma after minor injuries. Although actively debated, multiple observations indicate that stem/progenitor cells contribute to repair pervasive, chronic injuries. The most primitive of the stem/progenitor cells, biliary tree stem cells, are found in peribiliary glands within extrahepatic and large intrahepatic bile ducts. Biliary tree stem cells are comprised of multiple subpopulations with traits suggestive of maturational lineage stages and yet capable of self-replication and multipotent differentiation, being able to differentiate to mature liver cells (hepatocytes, cholangiocytes) and mature pancreatic cells (including functional islet endocrine cells). Hepatic stem cells are located within canals of Hering and bile ductules and are capable of differentiating to hepatocyte and cholangiocyte lineages. The existence, phenotype, and anatomical location of stem/progenitors in the adult pancreas are actively debated. Ongoing studies suggest that pancreatic stem cells reside within the biliary tree, primarily the hepatopancreatic common duct, and are rare in the pancreas proper. Pancreatic ducts and pancreatic duct glands harbor committed pancreatic progenitors. Conclusion: The hepatic, biliary, and pancreatic network of stem/progenitor cell niches should be considered as a framework for understanding liver and pancreatic regeneration after extensive or chronic injuries and for the study of human chronic diseases affecting these organs. (HEPATOLOGY 2016;64:277-286) 
C ommon precursors for liver, bile duct system, and pancreas exist at early stages of development in the definitive ventral endoderm forming the foregut (Fig. 1A) . (1, 2) In human development, the hepatic diverticulum emerges from the foregut. (3) The rostral part of the diverticulum forms the anlage of the liver and the common hepatic duct. The cells of the rostral part of the diverticulum bulge into the mesenchyme of the septum transversum as migrating cords of stem cells and alpha-fetoprotein 1 hepatoblasts. (3) The hepatoblasts have the potential to restrict their lineage either toward hepatocytes or cholangiocytes. (4) The stem cells and hepatoblasts around the mesenchyme of portal tracts form the ductal plate, which undergoes a process of remodeling leading to the formation of intrahepatic bile ducts (BDs) (Fig. 1B) . In pediatric and adult livers, the ductal plate transitions to become the canals of Hering (CoH). At the liver hilum, the elongation and branching of the common hepatic duct gives rise to the larger intrahepatic BDs (4) ; peribiliary glands (PBGs) progressively bud from the surface epithelium of the larger intrahepatic and extrahepatic BDs (Fig. 1C) . The caudal part of the hepatic diverticulum, connected to the foregut, gives rise to the extrahepatic biliary tree and ventral pancreas. At approximately 28-32 embryonic days in humans (10.5 in mice), the caudal part of the diverticulum harbors biliopancreatic stem/progenitors coexpressing SOX17 and PDX1. Further segregation of pancreatic and biliary precursors depends on specific transcription factors and signaling pathways ( Fig. 1A; Supporting Fig. S1 ). (5) In adults, biliopancreatic stem/progenitors are retained within PBGs along the biliary tree.
Dorsal and ventral pancreatic primordia derive from PDX1 1 /PTF1A 1 pancreatic stem/progenitors. (6) These progenitors, which can mature into all pancreatic parenchymal cells (acinar, ductal, and endocrine cells), branch into primitive epithelial tubules. (6) The growth of progenitor cells at the tips of tubules leaves behind a progeny that forms the trunk region of evolving tubules. Tip progenitors at the ends of tubules (PTF1A
) subsequently commit to exocrine lineages and differentiate into acinar and ductal cells. In the central duct area, NGN3
1 trunk progenitors commit to islet endocrine fates (Fig. 1A) . (6) On the basis of the progenitor segregation, multiple stem cell niches persist in specific anatomical locations within adult human organs: These stem/progenitor cell niches may contribute to repair pervasive, chronic injuries, whereas the replication of mature parenchymal cells ensures physiological turnover and restoration of parenchyma after minor injuries.
Biliary Tree Stem/ Progenitor Cells
In the human extrahepatic biliary tree, the stem/progenitor niches have been identified as the PBGs ( Fig.  2A) . (1, 7, 8) PBGs bud from the extrahepatic BD epithelium. (9) In adults, PBGs predominantly occur at branching points of the biliary tree and are most numerous at the hepatopancreatic ampulla. (7, 8) PBGs contain niches of cells, collectively termed BTSCs, with phenotypic traits of stem/progenitors of endodermal origin with respect to transcription factors (SOX17, PDX1, SOX9), surface markers (epithelial cell adhesion molecule [EpCAM], LGR5) and cytoplasmic markers, and the capacity of proliferation, self-renewal, and multipotency. (1, 7, 8, 10) A subpopulation (nearly 10%) of PBG cells appears to be primitive stem cells. These cells coexpress several pluripotency markers (e.g., OCT4, SOX2, NANOG); they can self-renew or differentiate into functional hepatocytes, cholangiocytes, and pancreatic islets. (7) There are no PBGs within the human gallbladder, but BTSC subpopulations are present in outpouchings of the surface epithelium (i.e., gallbladder crypts) and are later maturational lineage stages to those found within PBGs. (11) Interestingly, a radial axis has been described in the organization of BTSC niches (Fig. 2B) , mirroring that of the intestine. (8, 12) 
ARTICLE INFORMATION:
Niches containing BTSCs extend into the liver and to the pancreas. (8, 12) Large intrahepatic BDs display PBGs within their walls. Similarly, the largest pancreatic ducts display PDGs. Detailed anatomical studies in humans have revealed a proximal-to-distal axis (Fig.  3) for the BTSC niche organization going from the proximal location (the hepatopancreatic ampulla), where the most primitive stem cells reside, to the distal location (the liver or the pancreas), where mature cells reside. (8, 10, 12) This axis (Supporting Fig. S2 ) recapitulates the organogenesis of these organs, is based on their common embryological origin, (1) and is in accordance with the presence of a common stem cell compartment for the pancreas and the liver. (13) Recent studies suggest that, in adult life, PBG cells participate in the renewal of the surface epithelium of the extrahepatic BDs. (8, 14) Mature cholangiocytes themselves have high proliferative capabilities, and the turnover of biliary epithelium is primarily sustained by cholangiocyte proliferation. (15) However, PBG cells activate and participate in replacing damaged cholangiocytes in response to chronic BD injuries in rodent models (14) and in human primary sclerosing cholangitis (16) (17) (18) ; indeed, PBG loss leads to the formation of nonanastomotic biliary strictures after liver transplantation. (19) Although the role of the hedgehog pathway has been described, (16) the main signaling pathways driving expansion and differentiation of BTSCs still need to be elucidated.
Hepatic Stem/Progenitor Cells
In the human liver, a resident stem/progenitor cell compartment (Fig. 4A ) is present also in or adjacent to the CoH. (20, 21) HpSCs are capable of lineage restriction to mature hepatocytes and cholangiocytes. In vitro strategies have been used extensively to characterize these cells in fetal and adult human livers. (20) HpSCs and their descendants, hepatoblasts, can be isolated from human livers by immune selection for EpCAM, (22) a surface antigen expressed by cells that can self-replicate and that have multipotent capability. (23) The physiological turnover of mature liver parenchymal cells is ensured by proliferation of mature cells that are diploid; recent reports in adult mice showed that two distinct subpopulations of hepatocytes, namely "Axin2 1 cells" located pericentral and "Sox9 1 hybrid periportal hepatocytes" located periportal within liver lobule, contribute to hepatic regeneration. (24, 25) Therefore, it has been questioned whether stem cells are required for liver homeostatic maintenance. (20) Furuyama and associates demonstrated in mice that Sox9 1 stem/progenitors are the predominant source of new hepatocytes both in homeostatic liver regeneration and in recovery after injuries. (26) Subsequent lineagetracing studies in mice showed that HpSCs and their immediate descendants do not participate significantly in the physiological turnover of mature liver cells. (4, 27) Additional controversies (Supporting Table S1 arisen regarding the role of resident stem cells in liver regeneration after injuries. (28, 29) The explanation for this paradox is potentially in the models being used to analyze the phenomena. (28) The murine models of liver injury do not cause a severe blockade of hepatocyte proliferation (a blockade that instead characterizes human chronic liver diseases), thus limiting the need of HpSC activation in parenchymal renewal. (20) An elegant model in zebrafish showed that in severe, but not in moderate, hepatocyte ablation, cells of biliary origin extensively contributed to hepatocyte mass restoration. (30) In keeping, in a novel mouse model in which apoptosis, necrosis, and senescence are induced in nearly all hepatocytes, HpSC activation was crucial for survival and complete functional liver reconstitution. (31) Complementary findings in mice were obtained by Kaneko et al., demonstrating that hepatocyte injuries result in dramatic architectural changes in the biliary tree, the pattern of which is dictated by the type of injury. (32) FIG. 3. PBG and PDG distribution and proximal-to-distal axis of maturation in humans. The distribution of PBGs is not uniform along the human biliary tree. PBGs are mostly found in association with the hepatopancreatic duct, in the hepatopancreatic ampulla. A detailed anatomical study in humans showed that at the level of the hepatopancreatic ampulla the PBG network is connected with glandular elements, the PDGs, that reside within the wall of the main pancreatic duct. Comparison of cell phenotypic traits along human bile and pancreatic ducts supports the presence of a maturational lineage (proximal-to-distal axis). The highest number of primitive stem cells (positive for pluripotency markers such as Oct4A) is found in PBGs at the level of the human hepatopancreatic ampulla (remnant of endodermal multipotent precursors). Intrahepatic PBGs and intrapancreatic PDGs contain heterogeneous populations of stem cells and committed progenitor cells displaying limited expression of pluripotency markers and presenting lower proliferative capabilities; the expression of primitive phenotypic traits is progressively reduced along the length of the bile and pancreatic ducts. The progression toward the liver and intrahepatic branches of biliary tree implicates the gradual predominance of cells expressing restricted biliary (Sox17) and hepatic markers and the reduction of primitive (Oct4A) and pancreatic markers. In parallel, the progression toward the pancreas and branches of the main pancreatic duct is characterized by a gradual loss of primitive traits (Oct4A) and of hepatic/biliary markers and an acquisition of pancreatic markers (e.g., Ngn3, a marker of pancreatic islet progenitors) in PDGs. Images were taken from adult human organs. Yellow arrows in histological images indicate PBGs or PDGs; * indicates duct's lumen; # indicates liver or pancreatic parenchyma.
Notably, in human liver diseases, a severe and progressive impairment of hepatocyte proliferative capabilities is common. This is due to (1) chronic and prolonged hepatocyte loss leading to the exhaustion of hepatocyte proliferative capabilities and cellular senescence (33) and (2) the arrest of the hepatocyte cell cycle due to specific insults. (34) In human pathologies, the HpSC compartment activates and gives rise to the so-called ductular reaction (35) ; the ductular reaction is correlated with the progression of liver injury and represents the source of newly formed hepatocytes deriving from HpSCs. (36) Moreover, HpSC activation is a major mechanism for repopulation of cirrhotic livers through the formation of hepatocyte buds. (37) In summary, the proliferation of diploid mature hepatocytes and cholangiocytes ensures the physiological turnover of liver parenchymal cells and the restoration after low or mild regenerative demands. Although controversial, HpSCs activate in response to massive or chronic and prolonged parenchymal injuries and participate in the repopulation of damaged liver. The activation of HpSCs is driven by molecular signals 1 cell niche between hepatocyte cords and interlobular bile ducts (green arrow) is optimal for participation in the renewal of cholangiocytes or hepatocytes that are lost after specific injuries. (B) Main signaling pathways driving HpSC response. HpSC activation is driven by a specialized niche. The formation of a laminin-rich niche is necessary for the expansion of undifferentiated HpSCs. Tumor necrosis factor-like weak inducer of apoptosis produced by macrophages and osteopontin produced by HpSCs can sustain HpSC proliferation. Tissue-repairing macrophages are able to activate the canonical Wnt pathway in HpSCs, triggering their differentiation toward hepatocytes. The degradation of laminin-rich matrix is an essential step for hepatocyte fate differentiation. Activated hepatic stellate cells can secrete Jagged1, thus activating Notch signaling in HpSCs, and release type 1 collagen, promoting biliary specification. Proliferating HpSCs can induce a profibrogenic loop in nearby hepatic stellate cells through the Hedgehog pathway, osteopontin, and transforming growth factor-b1, thus inducing collagen 1 deposition. (C) In the adult human pancreas, a Sox9 1 cell population is located throughout the epithelium of ducts (arrows), including centroacinar cells (arrowhead). This niche has a role in the renewal of pancreatic ducts and acinar cells. The potential of this niche to participate in the turnover of endocrine islets has been at the center of a long-standing debate. Images were taken from adult human organs. Abbreviations: Hh, Hedgehog; Jag1, Jagged1; K7, keratin 7; OPN, osteopontin; TGF-b1, transforming growth factor-b1; Tweak, tumor necrosis factor-like weak inducer of apoptosis.
( Fig. 4B) furnished by a specialized niche composed of myofibroblasts/hepatic stellate cells, macrophages, and extracellular matrix components. (33, 35) 
Pancreatic Stem/Progenitor Cells
The existence, the phenotypic traits, and the anatomical location of stem/progenitor cells in the adult pancreas are actively debated. Although some reports claim the existence of multipotent stem cells within the pancreas, (38, 39) most suggest that these cells are rare in the postnatal pancreas. (40) Interestingly, recent studies indicate that cells with pancreatic stem cell traits persist postnatally in the human biliary tree, especially in the hepatopancreatic ampulla, whereas mostly or entirely committed progenitors reside in the pancreas proper. (10) Previous research focused on whether mature pancreatic cells are the source of regenerative phenomena. A large body of work suggests that in adults new pancreatic cells arise mainly from preexisting cells of the same lineage. In rodent models, lineage tracing studies showed that preexisting acinar cells give rise to acinar cells but not islets. (41) Islet b-cell expansion in adult life was instead reported to result mainly from the replication of preexisting islet b-cells. (42, 43) These findings do not preclude contribution from multiple populations of stem/progenitors for the de novo formation of exocrine and endocrine cells. (10, 38, 39, 44, 45) The epithelium of pancreatic ducts is composed of Sox9 1 (Fig. 4C ) and carbonic anhydrase II 1 cells. (13) Adult ductal cells can differentiate toward pancreatic acinar and endocrine cells. (44, 46) However, the contribution of this population to islet endocrine cell turnover is still a matter of debate. (13, 44, 46) In response to pathological conditions including pancreatitis and autoimmune diabetes, structures with heterogeneous ductal phenotypes expand in the pancreas-with a histological presentation that resembles the liver ductular reaction. (47, 48) Pancreatic endocrine progenitors have been observed in PDGs of the adult human pancreas. (10) PDGs occur in association with the main pancreatic duct and its immediate branches and are abundant in proximity to the hepatopancreatic ampulla (Supporting Fig. S2 ). (10, 49) Notably, PDGs undergo a major hyperplasia in murine models of chronic pancreatitis, presenting traits of mucinous intestinal metaplasia and pancreatic intraepithelial neoplasia. (49) The anatomical distribution of PDGs along the pancreatic ducts of larger caliber has similarities with the distribution of PBGs along the biliary tree. The cells in adult human PDGs along the larger pancreatic ducts present a phenotype consistent with that of pancreatic progenitors, and PDGs are found to harbor NGN3-positive cells, putative progenitors of islet cells. (10) Considered altogether, these observations suggest that the adult human pancreas contains niches of progenitors associated with ducts and PDGs and possibly mediating regenerative responses. Future investigations should aim at clarifying the sequence of events leading to activation of pancreatic progenitors in different pathological conditions. (45, 50) In analogy with phenomena observed in the biliary tree, (32) the expansion of pancreatic progenitors within pancreatic ducts and PDGs could result in architectural changes in response to different forms of insult. Moreover, upstream maturational events could take place in stem/progenitor cell niches of the biliary tree network, and this also could result into architectural changes that could precede pancreatic remodeling.
Clinical Relevance and Perspectives
The hepatic, biliary, and pancreatic network of stem/progenitor cell niches should be considered as a framework for understanding liver and pancreatic regeneration after extensive or chronic injuries and for the study of related diseases (Fig. 5) .
Chronic liver diseases affecting interlobular BDs or large intrahepatic BDs could differently activate HpSCs in CoH or BTSCs in PBGs, respectively. Interestingly, the human biliary tract and pancreas are affected by pathologies with clinical and pathological similarities. (17) The presence of closely related niches of stem/progenitors within PBGs and PDGs could explain why some human pathologies affect simultaneously the biliary tree and the pancreas. A typical example is represented by IgG4-Related Disease, which affects, in the same patient, the biliary tract and the pancreas.
Furthermore, these stem/progenitor cell niches could contain the cells of origin of liver (51, 52) and pancreatic (49) cancers. In perspective, evidence from experimental models of liver cirrhosis and diabetes makes human BTSCs a candidate source of stem/progenitors for regenerative medicine. (12, 18) Preclinical and clinical studies should focus on assessing the safety of using such cells in diseases characterized by pervasive parenchymal injury. Encouraging preliminary data from an ongoing phase 1/2 clinical trial indicated the safety of human BTSC administration for the treatment of advanced liver cirrhosis in patients not eligible for liver transplantation. (53) Key efforts should be made to assess parameters that can affect stem/progenitor cell function and maturation, to identify the best method and site of transplantation, and to evaluate the effects on clinical progress of the disease. Besides cell therapy, the modulation of BTSC differentiation toward a phenotype of interest could represent a possible therapeutic approach.
FIG. 5.
Multiple stem/progenitor cell niches are potentially involved in human inflammatory and neoplastic diseases of liver, biliary tree, and pancreas. The two stem cell compartments of the human liver, the Canals of Hering containing the hepatic stem/progenitor cells (HpSCs) and the peribiliary glands (PBGs) containing the biliary tree stem /progenitor cells (BTSCs), differently participate in the pathogenesis of specific human pathologies. (A) HpSCs are activated in human diseases affecting hepatocytes (such as chronic viral hepatitis or nonalcoholic fatty liver disease) or interlobular bile ducts (primary biliary cirrhosis). Activation of HpSCs determines the appearance of ductular reaction. HpSCs could represent the cell of origin of primary liver cancers. Specific subtypes of hepatocarcinoma and cholangiocarcinoma may originate from this compartment. Representative images were stained by immunohistochemistry for keratin 7. (B) By contrast, activation of BTSCs within human PBGs or of the progenitors in human pancreatic duct glands (PDGs) occurs in diseases affecting large intrahepatic and extrahepatic bile ducts (primary sclerosing cholangitis) or pancreatic ducts, respectively. Moreover, pure mucinous cholangiocarcinoma and pancreatic duct adenocarcinoma could originate from mucin-producing cells in PBGs or PDGs, respectively. Representative images were stained by immunohistochemistry for EpCAM and counterstained with periodic acid-Schiff. Abbreviations: CCA, cholangiocarcinoma; HCC, hepatocarcinoma; PBC, primary biliary cirrhosis; PDA, pancreatic duct adenocarcinoma; PSC, primary sclerosing cholangitis.
